Cargando…
The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor
Esophageal squamous cell carcinoma (ESCC) is an aggressive epithelial malignancy and the underlying molecular mechanisms remain elusive. Here, we identify that the ubiquitin-specific protease 39 (USP39) drives cell growth and chemoresistance by functional screening in ESCC, and that high expression...
Autores principales: | Zhu, Xiaolin, Ma, Jianlin, Lu, Minyi, Liu, Zhihua, Sun, Yongkun, Chen, Hongyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141838/ https://www.ncbi.nlm.nih.gov/pubmed/35627203 http://dx.doi.org/10.3390/genes13050819 |
Ejemplares similares
-
The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
por: Zhu, Xiaolin, et al.
Publicado: (2021) -
The Deubiquitinase USP39 Promotes ESCC Tumorigenesis Through Pre-mRNA Splicing of the mTORC2 Component Rictor
por: Zhao, Yuan, et al.
Publicado: (2021) -
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2
por: Wang, Shourong, et al.
Publicado: (2021) -
Targeting the deubiquitinase USP2 for malignant tumor therapy (Review)
por: Zhang, Shilong, et al.
Publicado: (2023) -
Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA
por: Ka, Hye In, et al.
Publicado: (2020)